Drug Shortage Report for VINBLASTINE SULPHATE INJECTION
Report ID | 245304 |
Drug Identification Number | 02401460 |
Brand name | VINBLASTINE SULPHATE INJECTION |
Common or Proper name | VINBLASTINE SULFATE INJECTION 10MG/10ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINBLASTINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-02-01 |
Actual start date | 2025-02-02 |
Estimated end date | 2025-04-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2025-02-03 | French | Compare |
v8 | 2025-02-03 | English | Compare |
v7 | 2025-02-02 | English | Compare |
v6 | 2025-01-17 | French | Compare |
v5 | 2025-01-17 | English | Compare |
v4 | 2024-12-20 | French | Compare |
v3 | 2024-12-20 | English | Compare |
v2 | 2024-12-10 | French | Compare |
v1 | 2024-12-10 | English | Compare |
Showing 1 to 9 of 9